A Selective Prevention Trial Using Novel Pharmacotherapies In An Older Age Cohort At Risk For Depression
Funder
National Health and Medical Research Council
Funding Amount
$975,259.00
Summary
The study will examine whether omega-3 fatty acids or antidepressants prevent the onset of depression in a group of older community participants who have previously been identified as being "at risk" of depression. The study will incorporate sophisticated brain scanning methods, as well as tests of brain functioning to determine acute brain changes, reduction in cognitive decline and prevention of depression over a one-year period.
A Randomised Controlled Trial Of Low-dose Ketamine In Youth With Severe Depression And Elevated Suicide Risk
Funder
National Health and Medical Research Council
Funding Amount
$2,232,757.00
Summary
Recent research has shown that a single injection of low-dose ketamine has powerful, though short-lived, antidepressant effects. Effective treatments are urgently needed for young people with severe depression. This will be the first controlled study to test whether repeated doses of ketamine, given over 4 weeks, is effective for young patients.
Examining New Treatments And Developing New Treatment Biomarkers For Youth With Severe Depression
Funder
National Health and Medical Research Council
Funding Amount
$338,381.00
Summary
Antidepressant medications and psychotherapy have been the mainstays of depression treatment in young people, but given their modest effectiveness, there is a pressing need for new treatment strategies. During this fellowship I aim to examine better treatments for depression, and develop better predictors about who is likely to benefit from them.
Role Of Neurogenesis In Clinical Recovery From Depression During ECT: Application Of A Novel In Vivo Magnetic Resonance Spectroscopy Technology
Funder
National Health and Medical Research Council
Funding Amount
$587,478.00
Summary
Neurogenesis refers to the generation of new brain cells, which is now known to continue well into adulthood. On the basis of animal studies, deficiencies in neurogenesis have been implicated in development of depression, and stimulation of neurogenesis proposed as one of the ways that anti-depressants may work. Using the latest technological advances in brain imaging, we will for the first time assess the merit of these theories in humans with depression before and after treatment.
Neural Predictors Of Treatment Response In Youth Depression
Funder
National Health and Medical Research Council
Funding Amount
$519,596.00
Summary
Depression is the single greatest cause of disability and morbidity in young people. In order to reduce its substantial burden on individuals and society, there is a need to optimise the early provision of existing treatments. In this study, we will use cutting-edge neuroimaging technology to identify “biomarkers” in the brain that will help to more accurately determine which available treatments are likely to be most effective and safe for an individual patient.
Refining Treatment Strategies For Youth Depression: Clinical Trials And Biomarker Development
Funder
National Health and Medical Research Council
Funding Amount
$339,221.00
Summary
Depression is the biggest contributor to disease burden of all illnesses suffered by young people. Despite this existing treatments are often not effective. The Career Development Fellowship will aid efforts to improve treatments for youth depression, by enabling the implementation of important clinical trials, and the identification and development of imaging biomarkers that can help to target treatments at patients most likely to benefit from them.
Investigating Neuroinflammation And Its Relationship With Progressive Brain Structural Loss In Schizophrenia
Funder
National Health and Medical Research Council
Funding Amount
$466,252.00
Summary
This project will investigate whether brain inflammation contributes to progressive brain volume loss in people with schizophrenia. Using novel brain scanning we will index whether brain cells involved in inflammation, called microglia, are in an activated state in people with schizophrenia. We expect microglia will be ‘activated’ in a subgroup of patients with schizophrenia, and will be related to progressive brain volume loss in these patients. This information will help us develop new treatme ....This project will investigate whether brain inflammation contributes to progressive brain volume loss in people with schizophrenia. Using novel brain scanning we will index whether brain cells involved in inflammation, called microglia, are in an activated state in people with schizophrenia. We expect microglia will be ‘activated’ in a subgroup of patients with schizophrenia, and will be related to progressive brain volume loss in these patients. This information will help us develop new treatments to prevent brain volume loss in the illness.Read moreRead less
An MRI Study Of Emotional Processing Deficits In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$578,985.00
Summary
The ability to recognise and process emotions in other people is fundamental to healthy social interactions. Conduct disordered children with callous and unemotional traits have difficulty recognizing fearful expressions, possibly due to lack of attention to cues such as facial expressions that healthy people naturally attend to. This study will use neuroimaging to determine if brain activity changes to look more like typically developing children if their gaze is redirected to facial cues of em ....The ability to recognise and process emotions in other people is fundamental to healthy social interactions. Conduct disordered children with callous and unemotional traits have difficulty recognizing fearful expressions, possibly due to lack of attention to cues such as facial expressions that healthy people naturally attend to. This study will use neuroimaging to determine if brain activity changes to look more like typically developing children if their gaze is redirected to facial cues of emotion.Read moreRead less